Patent EP0240131A2 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0240131A2 Expired / Lapsed EP ⏱️ 0.0 years remaining

Tamoxifen for topical use

Assignee: Imperial Chemical Industries Ltd
•
Filing: 1987-02-23
•
Granted: —
•
Expires: 2007-02-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention concerns a new therapeutic agent for use in treating psoriasis, new compositions of the therapeutic agent for topical administration and a new method of treating psoriasis.

Inventors

  • 👤 Hans Alfred Kraus

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-24 11:56
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/205; A61K31/13; A61K31/135; A61P; A61P17/00; A61P35/00

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 49 words
A process for the manufacture of a novel medicament for use in the treatment of psoriasis which comprises bringing a therapeutic agent selected from tamoxifen and the pharmaceutically acceptable salts thereof into a form suitable for topical administration by combining said agent with one or more dermatologically acceptable carriers.
Claim 2
Dependent Claim 49 words
A process for the manufacture of a novel medicament for use in the treatment of psoriasis which comprises bringing a therapeutic agent selected from tamoxifen and the pharmaceutically acceptable salts thereof into a form suitable for topical administration by combining said agent with one or more dermatologically acceptable carriers.
Claim 3
Dependent Claim 21 words
A process as claimed in claim 2 wherein the therapeutic agent is selected from tamoxifen and its D-gluconate and citrate salts.
Claim 4
Dependent Claim 30 words
The use of a therapeutic agent selected from tamoxifen and the pharmaceutically acceptable acid-addition salts thereof in the manufacture of a novel medicament for use in the treatment of psoriasis.
Claim 5
Dependent Claim 30 words
The use of a therapeutic agent selected from tamoxifen and the pharmaceutically acceptable acid-addition salts thereof in the manufacture of a novel medicament for use in the treatment of psoriasis.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag